In Part 1, we introduced SMB acquisition investing as an emerging, cash-flow-driven, private asset class that offers a risk-return profile distinct from early-stage venture capital, making it a potentially attractive tool for portfolio diversification. Now, we turn to the practical process of evaluating these opportunities.
- A Field Guide to Tourist Capital
- Your Brilliant Solution is Just the Start in Fundraising.
- Pyx Health Named to the Inc. 5000 List for the 5th Year in row
- The K-Shaped Meat Grinder – What a Record Venture Market Means for Regions That Will Never See It
- Linshom Medical Awarded Commercialization Innovation Grant
- Somewhere Right Now a Surgeon is Learning a Procedure for the Very First Time on a Real Person. ReSuture Changes This!
- Are Ecosystem Leaders Wasting Money on Accelerators?
- Regional Ecosystems Operate Inside an Accountability Vacuum
- NuvOx Therapeutics Receives FDA Fast Track Designation to NanO₂™ for the Treatment of Acute Ischemic Stroke
- $200MM and Counting: What’s Next for the Movement to Invest in Women Entrepreneurs